Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 single-ascending-dose study of adrecizumab in healthy male volunteers
NL-OMON43493Active, not recruiting
- Sponsor
- Adrenomed AG
- Start
- May 2016
- Modality
- IgG Antibodies → Naked Antibodies → Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Trial of adrecizumab, sponsored by Adrenomed AG. Started May 2016; status: active, not recruiting.
02
Drugs
adrecizumab
Beyond the preview
Go deeper on NL-OMON43493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43493.